Insurer and out-of-pocket costs of osteoarthritis in the US: Evidence from national survey data

Arthritis and Rheumatism

Volumn 60, Issue 12, 2009, Pages 3546-3553

  Kotlarz, Harry ^a   Gunnarsson, Candace L ^b   Fang, Hai ^c   Rizzo, John A ^d  

^a De Puy Inc   (United States)

^b S2 Statistical Solutions Inc   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COST OF ILLNESS; COST UTILITY ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONEY; OSTEOARTHRITIS; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; COMORBIDITY; COST OF ILLNESS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HISPANIC AMERICANS; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; OSTEOARTHRITIS; UNITED STATES; YOUNG ADULT;

EID: 73249153284     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24984     Document Type: Article

References (24)

1. Helmick CG, Felson DT, Lawrence RC, Gabriel C, Hirsch R, Kwoh CK, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum 2008;58: 15-25.
2. Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 2006; 54:226-9.
3. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol 1997;24:43-8.
4. Gabriel SE, Crowson CS, O'Fallon WM. Costs of osteoarthritis: estimates from a geographically defined population. J Rheumatol Suppl 1995;43:23-5.
5. Lanes SF, Lanza LL, Radensky PW, Yood RA, Meenan RF, Walker AM, et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 1997;40:1475-81.
6. Le Pen C, Reygrobellet C, Gerentes I. Financial cost of osteoarthritis in France: the "COART" France study. Joint Bone Spine 2005;72:567-70.
7. Levy E, Ferme A, Perocheau D, Bono I. Socioeconomic costs of osteoarthritis in France. Rev Rhum Ed Fr 1993;60:63S-7S. In French.
8. MacLean CH, Knight K, Paulus H, Brook RH, Shekelle PG. Costs attributable to osteoarthritis. J Rheumatol 1998;25;2213-8.
9. Leardini G, Salaffi F, Caporali R, Canesi B, Rovati L, Montanelli R, for the Italian Group for Study of the Costs of Arthritis. Direct and indirect costs of osteoarthritis of the knee. Clin Exp Rheumatol 2004;22:699-706.
10. Woo J, Lau E, Lau CS, Lee P, Zhang J, Kwok T, et al. Socioeconomic impact of osteoarthritis in Hong Kong: utilization of health and social services, and direct and indirect costs. Arthritis Rheum 2003;49:526-34.
11. Gupta S, Hawker GA, Laporte A, Croxford R, Coyte PC. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology (Oxford) 2005;44:1531-7.
12. Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C, for the Community Hypertension and Arthritis Project Study Team. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 2004;63:395-401.
13. Xie F, Thumboo J, Li SC. True difference or something else? Problems in cost of osteoarthritis studies. Semin Arthritis Rheum 2007;37:127-32.
14. Maetzel A. The challenges of estimating the national costs of osteoarthritis: are we making progress? J Rheumatol 2002;29: 1811-3.
15. Cohen J, Monheit A, Beauregard K. The Medical Expenditure Panel Survey: a national health information resource. Inquiry 1996;33:373-89.
16. Cragg J. Some statistical models for limited dependent variables with application to the demand for durable goods. Econometrica 1971;39:829-44.
17. Mullahy J. Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ 1998;17:247-81.
18. Buntin M, Zaslavsky A. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ 2004;23:525-42.
19. Agency for Healthcare Research and Quality. MEPS HC-096: 2005 medical conditions. Rockville, MD: AHRQ; 2007.
20. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum 2008;58: 26-35.
21. US Census Bureau. Statistical Abstract of the United States, 2009. URL: http://www.census.gov/compendia/statab/.
22. HealthWatch. To avoid arthritis, start when young. URL: http:// cbs5.com/health/Osteoarthritis.arthritis.health.2.285027.html.
23. Arthritis Foundation. Disease center: osteoarthritis. URL: http:// www.arthritis.org/disease-center.php?disease-id=32.
24. Harrold LR, Yood RA, Straus W, Andrade SE, Reed JI, Cernieux J, et al. Challenges of estimating health service utilization for osteoarthritis patients on a population level. J Rheumatol 2002 29:1931-6.